Mil'ko V I, Taradiĭ N N, Bagdasarova I V, Moskalenko N I, Ivanov D D
Lab Delo. 1989(2):27-8.
A modified method for the determination of glucocorticoid receptors in human lymphocytes is suggested. The principal distinction of the method is standardization by the lymphocyte count in a sample (1 mln) and the labeled hormone concentration. The modification saves time and money, limits the range of the data variations, and makes use of a lesser volume of blood. Examinations of 70 children aged 4 to 15 suffering from the nephrotic form of glomerulonephritis have made it possible to distinguish two groups of patients: with relatively high values of specific binding X = 6820.1 +/- 530.0 (n = 30, p = 0.95, t = 2.04), this corresponding to a clinical form of hormone-sensitive glomerulonephritis, and with relatively low values of specific binding X = 1815.2 +/- 302.8 (n = 40, p = 0.95, t = 1.96), that corresponds to hormone-resistant glomerulonephritis. Dynamic studies have not shown any statistically significant changes in the specific binding values. These results permit regarding the specific binding value as a prognostic criterion in the assessment of corticosteroid therapy; this allows a wide employment of the described method in practical nephrology.
本文提出了一种测定人淋巴细胞糖皮质激素受体的改良方法。该方法的主要区别在于通过样本中的淋巴细胞计数(100万个)和标记激素浓度进行标准化。这种改良节省了时间和金钱,限制了数据变化范围,并减少了血液用量。对70名4至15岁患有肾病型肾小球肾炎的儿童进行检查后,区分出了两组患者:一组患者的特异性结合值相对较高,X = 6820.1 +/- 530.0(n = 30,p = 0.95,t = 2.04),这对应于激素敏感性肾小球肾炎的临床类型;另一组患者的特异性结合值相对较低,X = 1815.2 +/- 302.8(n = 40,p = 0.95,t = 1.96),这对应于激素抵抗性肾小球肾炎。动态研究未显示特异性结合值有任何统计学上的显著变化。这些结果使得可以将特异性结合值作为评估皮质类固醇治疗的预后标准;这使得所描述的方法在实际肾脏病学中得到广泛应用。